Showing results (771-780 of 1,131) with videos related to
Sort By:
Pageof 114
Journal of the American Chemical Society|February 24, 2005
Rhodium boryl complexes in the catalytic, terminal functionalization of alkanesJohn F Hartwig, Kevin S Cook, Marko Hapke, et al.Hormones & Cancer|April 17, 2019
Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast CancerNicole C Lorona, Linda S Cook, Mei-Tzu C Tang, et al.Experimental Cell Research|July 20, 2001
Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null miceW S Cook, S Jain, Y Jia, et al.Journal of the National Cancer Institute|September 20, 1995
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancersL S Cook, N S Weiss, S M Schwartz, et al.Psychiatric Rehabilitation Journal|July 10, 2010
Outcomes of an illness self-management group using wellness recovery action planningVincent R Starnino, Susana Mariscal, Mark C Holter, et al.Journal of Health Care for the Poor and Underserved|November 8, 2016
Uranium Workers Demonstrate Lower Lobe Predominant Irregular Pneumoconiotic Opacities on Chest RadiographsElizabeth Kocher, Kristi J Rendon, Denece Kesler, et al.Cancer Epidemiology|February 5, 2015
Glycemic load and endometrial cancer risk in a case-control study of Canadian womenDarren R Brenner, Thomas Speidel, Ilona Csizmadi, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
CYP2D6 genotype and the incidence of anal and vulvar cancerC Chen, L S Cook, X Y Li, et al.Oncogene|June 6, 2017
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancersW Song, Y Hwang, V M Youngblood, et al.The Journal of General Virology|June 1, 1996
Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infectionR M Gaddum, R S Cook, S G Wyld, et al.Pageof 114